De Wolf F - Search Results

1

Syncytium-inducing and non-syncytium-inducing capacity of human immunodeficiency virus type 1 subtypes other than B: phenotypic and genotypic characteristics. WHO Network for HIV Isolation and Characterization.

De Wolf F, Hogervorst E, Goudsmit J, Fenyö EM, Rübsamen-Waigmann H, Holmes H, Galvao-Castro B, Karita E, Wasi C, Sempala SD, et al. De Wolf F, et al. AIDS Res Hum Retroviruses. 1994 Nov;10(11):1387-400. doi: 10.1089/aid.1994.10.1387. AIDS Res Hum Retroviruses. 1994. PMID: 7888192

2

Dehydroepiandrosterone as predictor for progression to AIDS in asymptomatic human immunodeficiency virus-infected men.

Mulder JW, Frissen PH, Krijnen P, Endert E, de Wolf F, Goudsmit J, Masterson JG, Lange JM. Mulder JW, et al. Among authors: de wolf f. J Infect Dis. 1992 Mar;165(3):413-8. doi: 10.1093/infdis/165.3.413. J Infect Dis. 1992. PMID: 1347053

3

Biphasic rate of CD4+ cell count decline during progression to AIDS correlates with HIV-1 phenotype.

Schellekens PT, Tersmette M, Roos MT, Keet RP, de Wolf F, Coutinho RA, Miedema F. Schellekens PT, et al. Among authors: de wolf f. AIDS. 1992 Jul;6(7):665-9. doi: 10.1097/00002030-199207000-00008. AIDS. 1992. PMID: 1354447

4

Concordance of human immunodeficiency virus detection by polymerase chain reaction and by serologic assays in a Dutch cohort of seronegative homosexual men.

Bruisten SM, Koppelman MH, Dekker JT, Bakker M, de Goede RE, Roos MT, de Wolf F, Coutinho RA, Goudsmit J, Huisman HG. Bruisten SM, et al. Among authors: de goede re, de wolf f. J Infect Dis. 1992 Sep;166(3):620-2. doi: 10.1093/infdis/166.3.620. J Infect Dis. 1992. PMID: 1500745

5

Markers for progression to AIDS during natural infection and antiviral therapy.

Goudsmit J, de Wolf F. Goudsmit J, et al. Among authors: de wolf f. Pathol Biol (Paris). 1992 Nov;39(9):873. Pathol Biol (Paris). 1992. PMID: 1538916 No abstract available.

6

Characterization of human antibody-binding sites on the external envelope of human immunodeficiency virus type 2.

de Wolf F, Meloen RH, Bakker M, Barin F, Goudsmit J. de Wolf F, et al. J Gen Virol. 1991 Jun;72 ( Pt 6):1261-7. doi: 10.1099/0022-1317-72-6-1261. J Gen Virol. 1991. PMID: 1710645

7

Contribution of antibody response to recombinant HIV-1 gene-encoded products nef, rev, tat, and protease in predicting development of AIDS in HIV-1-infected individuals.

Reiss P, de Wolf F, Kuiken CL, de Ronde A, Dekker J, Boucher CA, Debouck C, Lange JM, Goudsmit J. Reiss P, et al. Among authors: de ronde a, de wolf f. J Acquir Immune Defic Syndr (1988). 1991;4(2):165-72. J Acquir Immune Defic Syndr (1988). 1991. PMID: 1898969

8

Immune response to HIV p24 core protein during the early phases of human immunodeficiency virus infection.

McRae B, Lange JA, Ascher MS, de Wolf F, Sheppard HW, Goudsmit J, Allain JP. McRae B, et al. Among authors: de wolf f. AIDS Res Hum Retroviruses. 1991 Aug;7(8):637-43. doi: 10.1089/aid.1991.7.637. AIDS Res Hum Retroviruses. 1991. PMID: 1931233

9

Impairment of in vitro immune responses occurs within 3 months after HIV-1 seroconversion.

Teeuwsen VJ, Siebelink KH, de Wolf F, Goudsmit J, UytdeHaag FG, Osterhaus AD. Teeuwsen VJ, et al. Among authors: de wolf f. AIDS. 1990 Jan;4(1):77-81. doi: 10.1097/00002030-199001000-00011. AIDS. 1990. PMID: 1969282

10

Long-term zidovudine treatment of asymptomatic HIV-1-infected subjects.

Mulder JW, de Wolf F, Goudsmit J, Cload PA, Coutinho RA, Fiddian AP, Schellekens PT, van der Noordaa J, Lange JM. Mulder JW, et al. Among authors: de wolf f. Antiviral Res. 1990 Mar;13(3):127-38. doi: 10.1016/0166-3542(90)90028-6. Antiviral Res. 1990. PMID: 1972321

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

349 results

Search Page

Filters